Company intelligence / Profile preview
Meprofarm
Bandung, West Java, Indonesiameprofarm.com ↗
- Ownership
- Private
- Employees
- ~384
- Development stage
- Other
01
Overview
Meprofarm is an established Indonesian pharmaceutical manufacturer with a focus on high-quality drug production, including generics such as albendazole. The company operates two main manufacturing facilities and has capabilities for both oral solid and liquid dosage forms as well as injectables, creams, suppositories/ovula. It collaborates with other pharma companies for contract manufacturing and continues to invest in R&D for new product development[5][6].
- Therapeutic areas
- Infectious Diseases
- Modalities
- Small moleculeGeneric drug
- Industry
- Biotech
02
Drug pipeline
6 assets5 more assets in the full pipeline.
03
Partnerships
Collaborates with other pharmaceutical companies in Indonesia for contract/toll manufacturing
Beyond the preview
Go deeper on Meprofarm.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Meprofarm.